PORTLAND, OR – November 13, 2018 – ilo™ Vapor proudly announces the launch of DabTabs™, a revolutionary, patent-pending product that stands to change how cannabis is consumed. DabTabs offer an unprecedented solution for true cannabinoid vaporization via a convenient portable ‘tablet’ that acts as storage system for full spectrum extracts, concentrates and distillates offering precisely measured dosing.

ilo has partnered with Halo Labs (NEO:HALO) and MariMed Inc. (OTCQB: MRMD) to process, fill, and distribute DabTabs™ to dispensaries in seven states beginning in December 2018,

Dabbing is widely considered among cannabis connoisseurs and medical users to be the best way to experience the full spectrum of cannabinoids and terpenes.  Until now dabbing has been a messy, labor-intensive process that can be intimidating to new users and a nuisance for regular dabbers.

DabTabs are the first and only concentrate and extract delivery system that is stable and dry to the touch, allowing for a mess-free, full-spectrum dabbing experience without combustion. When DabTabs are heated, the material held inside vaporizes and is released without any excess residue.  With their unrivaled convenience and portability, DabTabs give consumers the optimal true vaporization experience. DabTabs will be sold in 500mg and 1000mg child resistant containers containing ten and twenty 50mg doses respectively.


“This extraordinary technology is empowering our partners to deliver products with unparalleled convenience,” said Michael Lindars, President and Co-founder of ilo Vapor. “Until now the storage and use of materials like shatter or live resin was a consumer’s and dispensary operator’s nightmare.  That’s over now.”

ilo has signed agreements with multi-state manufacturers and operators Halo Labs and MariMed Inc. to launch DabTabs in California, Nevada, Oregon, Massachusetts, Maryland, Delaware, and Rhode Island starting in December 2018 with more states to follow in the first quarter of 2019.

“Halo’s quality extracts, concentrates and distillates infused into DabTabs will elevate our customers’ dabbing experience and take vaporizing to new heights” shared Kiran Sidhu, CEO of Halo Labs. “We are extremely excited about our partnership with ilo and bringing their revolutionary products to market.”

“MariMed is laser focused on the most innovative and precision-dosed cannabis products on earth,” commented Bob Fireman, CEO of MariMed Inc.  “Ilo’s technology makes it easier for us to prepare, transport and store concentrates, while exponentially enhancing the convenience for consumers, particularly those new to the category.  It is a no-brainer to launch DabTabs on the East Coast in order to deliver this game changing product to market. “We are thrilled and look forward to a strong long-term partnership with ilo.”

ilo Vapor, will unveil DabTabs and will also introduce the TabRig™, a portable vaporizer designed to use DabTabs anywhere, and the varï™ battery at MJBizCon in Las Vegas on November 14th. Come find the team at MariMed’s booth number 1009. For more information, please contact michelle@iloVapor.com.


# # #


About ilo™ Vapor:

ilo Vapor, a division of Iconic Ventures, Inc., is a Portland, Oregon based technology, brand and product development company. Its patent pending devices are reinventing vaping. Through cutting edge technology and innovative design, ilo’s™ mission is to create clean, reliable and convenient products that deliver the optimal vaporization experience.

For more information, visit ilovapor.com

Follow ilo Vapor on Instagram @ilo.vapor and LinkedIn https://www.linkedin.com/company/ilo-vapor/


About Halo Labs:

Halo is a cannabis extraction company that develops and manufactures quality cannabis oils and concentrates, which are the fastest growing segments in the cannabis industry.  Halo has expertise in all major cannabis manufacturing processes, leveraging proprietary processes and products, and has produced over 2.7M grams of oils and concentrates since inception.  The forward-thinking company is led by a strong management team with deep industry knowledge and blue-chip experience.  The Company is currently operating in Nevada and Oregon and is expanding into California this month.  With a consumer-centric focus, Halo will continue to market innovative branded and private label products across multiple product categories.

For further information regarding Halo, see Halo’s disclosure documents on SEDAR at www.sedar.com.
About MariMed Inc:

MariMed is a multi-state cannabis operator  that has developed state-of-the-art regulatory-compliant facilities in DE, IL, NV, MD, MA, and RI, which are models of excellence in horticultural principals, cannabis production, product development, and dispensary operations.  In addition, MariMed is on the forefront of precision-dosed branded products for the treatment of specific medical symptoms. MariMed currently distributes its branded products in select states and is expanding licensing and distribution to numerous additional markets encompassing thousands of dispensaries. MariMed Inc. is one of the 17 top-performing public cannabis companies in the U.S. tracked on the U.S. Marijuana Index, (www.marijuanaindex.com). For additional information, visit www.MariMedAdvisors.com.  Search MariMed and post on social media with the hash tag #MedicatedByMarimed:

Twitter: @MariMedInc

Facebook: @MariMedInc

Instagram:  MariMedInc

YouTube: MariMedInc



For ilo™ Vapor

Michelle Lindars



Media Contact:

Farley Cahen

Elevated Agency




For Halo Labs 

Collin Beloin

Investor Relations




For MariMed

Business Development

Jon Levine, CFO, MariMed



Investor Relations

Tyler Troup, Circadian Group


+1 (866) 950 8300

Media Relations

Julie Shepherd, Accentuate PR




Halo Labs: Cautionary Note Regarding Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Halo’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Halo’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”.  

By identifying such information and statements in this manner, Halo is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Halo to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Halo has made certain assumptions.

Although Halo believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Halo does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to Halo or persons acting on its behalf is expressly qualified in its entirety by this notice.


MariMed Inc: Forward Looking Statements:

This release contains certain forward-looking statements and information relating to MariMed Inc., that is based on the beliefs of MariMed Inc.’s management, as well as assumptions made by and information currently available to the Company. Such statements reflect the current views of the Company with respect to future events including estimates and projections about its business based on certain assumptions of its management, including those described in this Release. These statements are not guarantees of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company’s services and products, changes in the law and its enforcement and changes in the economic environment. Additional risk factors are included in the Company’s public filings with the SEC. Should one or more of these underlying assumptions prove incorrect, actual results may vary materially from those described herein as “hoped,” “anticipated,” “believed,” “planned, “estimated,” “preparing,” “potential,” “expected” or words of a similar nature. The Company does not intend to update these forward-looking statements. None of the content of any of the websites referred to herein (even if a link is provided for your convenience) is incorporated into this release and the Company assumes no responsibility for any of such content.